-
Hyderabad: The special vaccination drive for adolescents between the age groups of 15 years and 18 years launched on January 3, is underway in Telangana at a brisk place. Within a week, government and private healthcare facilities have completed administering first dose of Covid vaccine to 37 per cent of the beneficiaries in 15 years […]
-
Hyderabad: According to the announcement made by the Central government, appointments for the precautionary dose of the Covid-19 vaccine in India will begin from Saturday evening. te. The eligible population – healthcare workers, frontline workers, and those above 60 years of age with comorbidities – who have already taken two doses of the vaccine, can […]
-
Hyderabad: Bharat Biotech, the maker of Covid-19 vaccine Covaxin, issued a fact check in response to certain media reports about the vaccine. Referring to a report dated December 29th 2021 by Moneycontrol, which stated, “No one can quite say how India’s indigenous Covid-19 vaccine company will meet the challenge of vaccinating close to 10 crore […]
-
Hyderabad: Vaccine maker Bharat Biotech on Wednesday clarified that Paracetamol or pain killers are not recommended for teenagers after being vaccinated with Covaxin. “We have received feedback that certain immunisation centres are recommending taking 3 paracetamol 500 mg tablets along with Covaxin for children. No paracetamol or painkillers are recommended after being vaccinated with Covaxin,” […]
-
Hyderabad: Ten per cent of the eligible beneficiaries between the age group of 15 and 18 years in Telangana have received the first dose of Covid vaccine, according to the health bulletin here on Wednesday. The Covid vaccine administration drive for adolescents was launched on January 3 and within three days, about 10 per cent, […]
-
New Delhi: With the vaccination drive for adolescents entering its third day, as per the Co-WIN portal 1,06,27,277 children in the 15 to 18 years’ age group have been vaccinated with the first Covid-19 vaccine dose so far. According to the government’s Co-WIN portal, 1,33,64,030 children have registered so far for the first dose of […]
-
New Delhi: The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech’s application for clinical trials of its intranasal Covid vaccine as a booster or a third dose. The Hyderabad-based manufacturer has proposed the booster dose for those who have been […]
-
Hyderabad: A mix and match of Covishield and Covaxin has the ability to elicit a robust antibody response against SARS-CoV-2, a pilot study taken-up by city-based Asian Institute of Gastroenterology (AIG) Hospitals on Monday said. The AIG study also has indicated that 87 percent of the participants in the study, who were not vaccinated and […]
-
As announced by Prime Minister Narendra Modi on December 25, 2021, the vaccination for the age-group 15-18 years is scheduled to begin from January 3, 2022.
-
Hyderabad: Stage is set for the launch of Covid vaccination drive for youngsters aged between 15 years and 18 years in Telangana from Monday. The preparations to administer Covid vaccines at designated government Covid vaccination centres in districts and areas under Greater Hyderabad Municipal Corporation (GHMC) have been completed by the State Health Department. There […]
-
Hyderabad: Bharat Biotech International Limited (BBIL), on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Bharat Biotech had conducted phase II/III, open-label, and multicenter studies to evaluate the safety, reactogenicity, and immunogenicity of Covaxin in healthy children […]
-
New Delhi: Registration process for adolescents’ vaccination on Cowin App will begin from January 1, Cowin Platform Chief Dr RS Sharma said on Monday. Eligible teens can register themselves on the Cowin app through their Aadhar Card and school IDs. The registration process will begin from January 1 for teens using their Aadhar Card. He […]
-
Hyderabad: Bharat Biotech on Saturday said it received DCGI approval for emergency use of Covaxin for children aged 12-18 years. The vaccine has established a proven record for safety and efficacy in adults for the original variant and subsequent variants. “We have documented excellent safety and immunogenicity data readouts in children. We look forward for […]
-
New Delhi: Prime Minister Narendra Modi on Saturday announced that the COVID-19 vaccination for children aged 15-18 years will start from January 3. This comes after Bharat Biotech’s COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, said official sources. In […]
-
Hyderabad: Explaining its 28 days open vial policy, Hyderabad-based Bharat Biotech on Monday stated that healthcare workers do not have to worry about opening Covaxin’s vial and its wastage. This means that an open Covaxin vial can be used up to 28 days post opening and would not go waste if there are no people […]
-
New Delhi: Hyderabad-based Bharat Biotech Chairman Dr Krishna Ella along with Joint Managing Director Suchitra Ella visited the Professor Dr Tran Van Thuan, Deputy Minister of Health, Government of the Socialist Republic of Vietnam, in New Delhi. As per sources, they discussed the Covaxin Covid-19 vaccination to cover children below 18 years in Vietnam. According […]
-
Hyderabad: The Republic of Vietnam will receive two lakh doses of Bharat Biotech’s Covaxin. This donation represents a goodwill gesture to provide access to the company’s WHO approved, indigenously developed Covaxin to fight the Covid-19 pandemic across borders. Covaxin has received emergency use listing in Vietnam. Suchitra Ella, joint managing director of Bharat Biotech, revealed this at […]
-
Hyderabad: Hyderabad-based Covid-19 vaccine (Covaxin) maker Bharat Biotech on Monday said the company has commenced the exports of the vaccine. “Long pending export orders have been executed during November, to be further expanded during the following months. With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries […]
-
The resurgence of Covid-19 in Europe and the United States and the fear of a similar surge in infections during the months of winter have fuelled the demand for booster Covid vaccines in India. In a desperate attempt to contain the surge, many countries in Europe have gone into lockdown and have also launched massive […]
-
Dubai: NRIs, who are residents of Kuwait and other Gulf countries, who received Covaxin in India are anxiously following latest developments as thousands of them are stranded back home as many Gulf countries have not recognised Covaxin yet. The Indian Embassy in Kuwait announced a fresh registration drive for stranded Indian nationals who have not […]